The US has officially got a homegrown hero in the burgeoning global industry of effective weight-loss treatments, with the FDA approval of Eli Lilly’s Zepbound. The company has announced the once-a-week injectable drug's cost, dosages, insurance subsidies and when it will be on shelves.| New Atlas
Zepbound is here! With Tirzepatide FDA approval for obesity, Lily release the new Mounjaro for weight loss obesity treatment, Zepbound. Learn all about it.| Keto Dirty
Discover how GLP-1 agonists, known for treating diabetes and obesity, are now being studied for their potential in tackling heart diseases.| Labiotech.eu